Using the Translational Science Benefits Model to assess the impact of the Penn Implementation Science Center in Cancer Control.

ABSTRACT: Traditional approaches for evaluating the impact of scientific research - mainly scholarship (i.e., publications, presentations) and grant funding - fail to capture the full extent of contributions that come from larger scientific initiatives. The Translational Science Benefits Model (TSBM) was developed to support more comprehensive evaluations of scientific endeavors, especially research designed to translate scientific discoveries into innovations in clinical or public health practice and policy-level changes. Here, we present the domains of the TSBM, including how it was expanded by researchers within the Implementation Science Centers in Cancer Control (ISC3) program supported by the National Cancer Institute. Next, we describe five studies supported by the Penn ISC3, each focused on

SUBMITTER: Schnoll R 

PROVIDER: S-EPMC11604509 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature